A Review of Keratoconus Cross-Linking Treatment Methods
Journal of Clinical Medicine · 03.03.2025 · 14 (5) · 1702
DOI: 10.3390/jcm14051702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.03.2025. Verfasst von Natalie Papachristoforou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ministry Hospital of Internal Affairs and Administration, 30-053 Krakow, Poland. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Corneal collagen cross-linking (CXL) is a therapeutic intervention that utilizes riboflavin photochemical activation with ultraviolet-A (UV-A) light to induce covalent cross-links within the stromal corneal fibers, effectively increasing corneal biomechanical stability and halting the progressive ectasia. The method was introduced in the late 1990s in Germany at the University of Dresden. The cross-linking method using the Avedro system (Waltham, MA, USA) was approved by the US Food and Drug Administration (FDA) on 18 April 2016, based on three prospective, multicenter, randomized clinical trials for keratoconus and other corneal ectasias. Recent innovations in CXL include a range of new treatment protocols and methods, which have been introduced to further enhance the clinical effectiveness, efficiency, and safety of CXL. These modifications encompass approaches like transepithelial or epithelium-on CXL (TE-CXL or epi-on CXL), accelerated CXL (ACXL), pulsed CXL (PL-CXL), transepithelial iontophoresis-assisted crosslinking (I-CXL), diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL), slit-lamp CXL, and CXL plus (combined) methods. This review synthesizes findings on currently used modifications of the cross-linking method, the effectiveness, and directions of development of this currently dominant surgical method of treating corneal ectasia. This review concentrates on the long-term follow-up data, based on publications ranging from 1998 up to 2023.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ministry Hospital of Internal Affairs and Administration, 30-053 Krakow, Poland.
- Stefan Zeromski Specialist Hospital, Independent Public Healthcare Institution, 31-913 Krakow, Poland.
- Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Clinic of Ophthalmology and Ocular Oncology, University Hospital, 30-688 Krakow, Poland.
- Faculty of Medicine, Department of Ophthalmology and Ocular Oncology, Jagiellonian University Medical College, 31-008 Krakow, Poland.
ORCID-Profile: Natalie Papachristoforou, Anthony Ueno, Kamila Ledwos, Jerzy Bartuś, Anna Nowińska, Izabella Karska-Basta
Zitieren
APA
Papachristoforou, N., Ueno, A., Ledwos, K., Bartuś, J., Nowińska, A., & Karska-Basta, I. (2025). A Review of Keratoconus Cross-Linking Treatment Methods. Journal of Clinical Medicine, 14(5), 1702. https://doi.org/10.3390/jcm14051702
Vancouver
Papachristoforou N, Ueno A, Ledwos K, Bartuś J, Nowińska A, Karska-Basta I. A Review of Keratoconus Cross-Linking Treatment Methods. Journal of Clinical Medicine. 2025;14(5):1702. doi:10.3390/jcm14051702
BibTeX
@article{Papachristoforou2025,
author = {Papachristoforou, Natalie and Ueno, Anthony and Ledwos, Kamila and Bartuś, Jerzy and Nowińska, Anna and Karska-Basta, Izabella},
title = {A Review of Keratoconus Cross-Linking Treatment Methods},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {5},
pages = {1702},
doi = {10.3390/jcm14051702}
}
EUVIMED